ArticleBone marrow transplantation2023

Avapritinib is effective for treatment of minimal residual disease in acute myeloid leukemia with t (8;21) and kit mutation failing to immunotherapy after allogeneic hematopoietic stem cell transplantation.

Jun Kong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.